US 8691813
Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
granted A61PA61P25/00A61P25/06
Quick answer
US patent 8691813 (Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors) held by Addex Pharma, S.A. expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Addex Pharma, S.A.
- Grant date
- Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P25/00, A61P25/06, A61P25/08, A61P25/12